Site/Facility Readiness Assessment Tool to Support Lenacapavir for HIV Prevention Introduction

by Efua Owusu | Mar 30, 2026

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in...

Tools for Active Safety Surveillance of Maternal and Infant Health Outcomes for Pregnant and Breastfeeding Users of Oral PrEP and PrEP Ring

by Efua Owusu | Mar 30, 2026

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in...

Human Immunodeficiency Virus Treatment and Prevention for Pregnant and Postpartum Women in Global Settings

by Efua Owusu | Mar 10, 2026

Review and description of current HIV prevention, specifically PMTCT, strategies in pregnant and breastfeeding women, including ART during pregnancy/breastfeeding and lifelong ART for women living with HIV, PrEP use during pregnancy/breastfeeding for women not living...

Long-Acting Injectable Antiretroviral Drugs for Pregnant and Breastfeeding Women: Current Advances, Challenges, and Future Directions

by Efua Owusu | Mar 5, 2026

Assessment of Facility Readiness for PrEP Provision in Antenatal and Postnatal Care Services

by Janette Afsharian | Mar 4, 2026

This tool was originally developed through the CHOICE initiative, a 24-month collaboration funded by USAID, in partnership with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through the EpiC and RISE projects. The resources were updated and refined by...